Health-related Quality of Life Measurement Tools for Lymphedema: A Review of the Literature

Pelicia Lim, Henry Li, Derek Neoh, Sally Kiu-Huen Ng, Pelicia Lim, Henry Li, Derek Neoh, Sally Kiu-Huen Ng

Abstract

Lymphedema can significantly affect patients' health-related quality of life (HRQoL). Various quality of life scales have been developed to assess the extent of the disease burden. The purpose of this study is to review various HRQoL instruments that have been used in lymphedema studies and compare their qualities against the COSMIN checklist.

Methods: A systematic literature review search was conducted for clinical lymphedema studies published between January 1, 1984, and February 1, 2020, using Pubmed database. All clinical lymphedema studies which used HRQoL instruments as outcome measures were identified.

Results: One thousand seventy-six studies were screened-of which, 288 studies were individually assessed. Thirty-nine HRQoL instruments were identified in these clinical lymphedema studies. Of these, there are eight lymphedema-specific questionnaires that cover all HRQoL domains, all of which have been validated for use in lymphedema. We contrasted the two most popular questionnaires [LYMQOL and Upper Limb Lymphedema (ULL)-27] and compared their features.

Conclusion: There is currently no ideal lymphedema HRQoL measurement tool available based on the COSMIN criteria. However, our review suggested that LYMQOL and ULL-27 are the most used and most validated instruments at present, but each has their own limitations. We recommend the use of LYMQOL and ULL-27 for future studies to allow direct HRQoL comparison to current literature. Further research is required to develop an optimal HRQoL questionnaire that can ultimately become the gold standard HRQoL instrument for lymphedema.

Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.

Figures

Fig. 1.
Fig. 1.
Schematic presentation of systematic review process.

References

    1. DiSipio T, Rye S, Newman B, et al. . Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14:500–515.
    1. Moffatt CJ, Franks PJ, Doherty DC, et al. . Lymphoedema: an underestimated health problem. QJM. 2003;96:731–738.
    1. Rockson SG, Rivera KK. Estimating the population burden of lymphedema. Ann N Y Acad Sci. 2008;1131:147–154.
    1. Cormier JN, Askew RL, Mungovan KS, et al. . Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer. 2010;116:5138–5149.
    1. Morgan PA, Franks PJ, Moffatt CJ. Health-related quality of life with lymphoedema: a review of the literature. Int Wound J. 2005;2:47–62.
    1. Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema. Am J Surg. 1999;177:184–187; discussion 188.
    1. Földi E, Földi M, Weissleder H. Conservative treatment of lymphoedema of the limbs. Angiology. 1985;36:171–180.
    1. Brorson H, Svensson H. Complete reduction of lymphoedema of the arm by liposuction after breast cancer. Scand J Plast Reconstr Surg Hand Surg. 1997;31:137–143.
    1. Thompson N. Surgical treatment of chronic lymphoedema of the lower limb. With preliminary report of new operation. Br Med J. 1962;2:1566–1573.
    1. Li L, Yuan L, Chen X, et al. . Current treatments for breast cancer-related lymphoedema: a systematic review. Asian Pac J Cancer Prev. 2016;17:4875–4883.
    1. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118:622–629.
    1. Ferrell BR, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res. 1995;4:523–531.
    1. Higginson IJ, Carr AJ. Measuring quality of life: using quality of life measures in the clinical setting. BMJ. 2001;322:1297–1300.
    1. Muldoon MF, Barger SD, Flory JD, et al. . What are quality of life measurements measuring? BMJ. 1998;316:542–545.
    1. Fu MR, Axelrod D, Cleland CM, et al. . Symptom report in detecting breast cancer-related lymphedema. Breast Cancer (Dove Med Press). 2015;7:345–352.
    1. Devoogdt N, Van Kampen M, Geraerts I, et al. . Lymphoedema functioning, disability and health questionnaire (Lymph-ICF): reliability and validity. Phys Ther. 2011;91:944–957.
    1. Ridner SH, Dietrich MS. Development and validation of the lymphedema symptom and intensity survey-arm. Support Care Cancer. 2015;23:3103–3112.
    1. Launois R, Megnigbeto AC, Pocquet K, et al. . A specific quality of life scale in upper limb lymphedema: the ULL-27 questionnaire. Lymphology. 2002;35:181–187.
    1. Keeley V, Crooks S, Locke J, et al. . A quality of life measure for limb lymphoedema (LYMQOL). J Lymphoedema. 2010;5:26–37.
    1. Klernäs P, Johnsson A, Horstmann V, et al. . Lymphedema Quality of Life Inventory (LyQLI)-development and investigation of validity and reliability. Qual Life Res. 2015;24:427–439.
    1. Augustin M, Bross F, Földi E, et al. . Development, validation and clinical use of the FLQA-l, a disease-specific quality of life questionnaire for patients with lymphedema. Vasa. 2005;34:31–35.
    1. Weiss J, Daniel T. Validation of the Lymphedema Life Impact Scale (LLIS): a condition-specific measurement tool for persons with lymphedema. Lymphology. 2015;48:128–138.
    1. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27(Suppl 3):S217–S232.
    1. MacKeigan LD, Pathak DS. Overview of health-related quality-of-life measures. Am J Hosp Pharm. 1992;49:2236–2245.
    1. Mokkink LB, Terwee CB, Patrick DL, et al. . The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63:737–745.
    1. de Souza AC, Alexandre NMC, de Brito Guirardello E. Psychometric properties in instruments evaluation of reliability and validity. Epidemiol Serv Saude. 2017;26:649–659.
    1. Streiner DL. Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Pers Assess. 2003;80:99–103.
    1. Terwee CB, Bot SD, de Boer MR, et al. . Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42.
    1. Kimberlin CL, Winterstein AG. Validity and reliability of measurement instruments used in research. Am J Health Syst Pharm. 2008;65:2276–2284.
    1. Polit DF, Beck CT. Fundamentos de pesquisa em enfermagem: avaliação de evidências para a prática da enfermagem. Artmed Editora; 2011.
    1. Polit DF. Assessing measurement in health: Beyond reliability and validity. Int J Nurs Stud. 2015;52:1746–1753.
    1. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Academic Press; 2013.
    1. Higgins JP, Thomas J, Chandler J, et al. . Cochrane Handbook for Systematic Reviews of Interventions. John Wiley & Sons; 2019.
    1. Mokkink LB, Terwee CB, Patrick DL, et al. . The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19:539–549.
    1. Cella DF, Tulsky DS, Gray G, et al. . The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570–579.
    1. List MA, D'Antonio LL, Cella DF, et al. . The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy‐head and neck scale: a study of utility and validity. Cancer. 1996;77:2294–2301.
    1. Askew RL, Swartz RJ, Xing Y, et al. . Mapping FACT-melanoma quality-of-life scores to EQ-5D health utility weights. Value Health. 2011;14:900–906.
    1. Askew RL, Xing Y, Palmer JL, et al. . Evaluating minimal important differences for the FACT‐Melanoma quality of life questionnaire. Value Health. 2009;12:1144–1150.
    1. Schipper H, Clinch J, McMurray A, et al. . Measuring the quality of life of cancer patients: the functional living index-cancer: development and validation. J Clin Oncol. 1984;2:472–483.
    1. Lim MC, Lee JS, Joo J, et al. . Development and evaluation of the Korean version of the Gynecologic Cancer Lymphedema Questionnaire in gynecologic cancer survivors. Gynecol Oncol. 2014;133:111–116.
    1. Zebrack BJ, Ganz PA, Bernaards CA, et al. . Assessing the impact of cancer: development of a new instrument for long-term survivors. Psychooncology: Journal of the Psychological, Social and Behavioral Dimensions of Cancer. 2006;15:407–421.
    1. Fu MR, Axelrod D, Cleland CM, et al. . Symptom report in detecting breast cancer-related lymphedema. Breast Cancer: Targets Ther. 2015;7:345.
    1. Augustin M, Bross F, Földi E, et al. . Development, validation and clinical use of the FLQA-l, a disease-specific quality of life questionnaire for patients with lymphedema. Vasa. 2005;34:31–35.
    1. Cemal Y, Jewell S, Albornoz CR, et al. . Systematic review of quality of life and patient reported outcomes in patients with oncologic related lower extremity lymphedema. Lymphat Res Biol. 2013;11:14–19.
    1. Carmeli E, Bartoletti R. Retrospective trial of complete decongestive physical therapy for lower extremity secondary lymphedema in melanoma patients. Supportive Care Cancer. 2011;19:141–147.
    1. Armer JM, Radina ME, Porock D, et al. . Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res. 2003;52:370–379.
    1. Devoogdt N, Van Kampen M, Geraerts I, et al. . Lymphoedema functioning, disability and health questionnaire (Lymph-ICF): Reliability and validity. Phys. Ther. 2011;91:944–957.
    1. Weiss J, Daniel T. Validation of the Lymphedema Life Impact Scale (LLIS): a condition-specific measurement tool for persons with lymphedema. Lymphology. 2015;48:128–138.
    1. Ridner SH, Dietrich MS. Development and validation of the lymphedema symptom and intensity survey-arm. Supportive Care Cancer. 2015;23:3103–3112.
    1. Klernas P, Kristjanson L, Johansson K. Assessment of quality of life in lymphedema patients: validity and reliability of the Swedish version of the Lymphedema Quality of Life Inventory (LQOLI). Lymphology. 2010;43:135–145.
    1. Keeley V, Crooks S, Locke J, et al. . A quality of life measure for limb lymphoedema (LYMQOL). J Lymphoedema. 2010;5:26–37.
    1. Launois R, Megnigbeto AC, Pocquet K, et al. . A specific quality of life scale in upper limb lymphedema: the ULL-27 questionnaire. Lymphology. 2002;35:181–187.
    1. Weiss J, Spray B. The effect of complete decongestive therapy on the quality of life of patients with peripheral lymphedema. Lymphology. 2002;35:46–58.
    1. Mirolo BR, Bunce IH, Chapman M, et al. . Psychosocial benefits of postmastectomy lymphedema therapy. Cancer Nursing. 1995;18:197–205.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel